Quince Therapeutics
QNCX
#9113
Rank
NZ$0.13 B
Marketcap
$3.15
Share price
1.14%
Change (1 day)
75.53%
Change (1 year)

Quince Therapeutics (QNCX) - Cash on Hand

Cash on Hand as of September 2024 : NZ$84.69 Million

According to Quince Therapeutics's latest financial reports the company has NZ$84.69 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Quince Therapeutics - Cash on Hand chart (from 2018 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31NZ$0.14 B-9.16%
2021-12-31NZ$0.15 B-15.69%
2020-12-31NZ$0.18 B25.08%
2019-12-31NZ$0.14 B38.69%
2018-12-31NZ$0.10 B934.07%
2017-12-31NZ$10.33 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.48 B 469.25%๐Ÿ‡บ๐Ÿ‡ธ USA